Centre Hospitalier Régional Universitaire de Nancy.
Vandœuvre-lès-Nancy, 54500, France
NCT Number: NCT05224830
Following an acute COVID-19 infection, many patients suffer from long lasting physical symptoms that may greatly impair quality of life. Persisting dyspnea and other functional respiratory complaints could evoke Hyperventilation Syndrome (HVS) as a putative contributor of the long-COVID presentation in COVID-19 survivors. We aimed to assess the possible relationship between a HVS and previous acute SARS-CoV-2 infection.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Vandœuvre-lès-Nancy, 54500, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
We collected the Nijmegen Questionnaire in order to diagnosis of Hyperventilation Syndrome
Time frame: Nijmegen questionnaire during 15 minutes (cross-sectional monocentric study)
Time frame: Nijmegen questionnaire during 15 minutes (cross-sectional monocentric study)
Central Hospital, Nancy, France
Other
A Cross-sectional Study : Is There a Relationship Between Hyperventilation Syndrome and History of Acute SARS-CoV-2 Infection?
Acronym: Hypercovid
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07184372
COVID-19, Coronaviridae Infections
Córdoba, Cordoba, Spain
View Trial DetailsNCT07000331
Anxiety Disorders, Behavior
Izmir, Turkey (Türkiye)
View Trial DetailsNCT06165835
COVID-19, Chronic Disease
Taipei, Taiwan
View Trial DetailsNCT05139979
Anxiety Disorders, Behavior
Boston, Massachusetts, United States
View Trial Details